Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial-Reference-Cited by-同舟云学术

Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial

Published:2016-07 Issue:1 Volume:52 Page:8-16.e1
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

Hui David,Kilgore Kelly,Frisbee-Hume Susan,Park Minjeong,Tsao Anne,Delgado Guay Marvin,Lu Charles,William William,Pisters Katherine,Eapen George,Fossella Frank,Amin Sapna,Bruera Eduardo

Funder

MD Anderson Cancer Center

American Cancer Society

National Institutes of Health

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,General Nursing

Reference36 articles.

1. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea;Parshall;Am J Respir Crit Care Med,2012

2. Dyspnea in cancer patients: prevalence and associated factors;Dudgeon;J Pain Symptom Manage,2001

3. Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death;Tishelman;J Clin Oncol,2007

4. Symptom expression in the last 7 days of life among cancer patients admitted to acute palliative care units;Hui;J Pain Symptom Manage,2015

5. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis;Ben-Aharon;Acta Oncol,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine;Journal of Palliative Medicine;2024-07-25

2. β-Elemene in zedoary turmeric oil injection induces dyspnea by binding to hemoglobin and upregulating HIF-1α;Journal of Ethnopharmacology;2024-03

3. A systematic review and meta-analysis of systemic corticosteroids for the palliation of dyspnea in patients with cancer;2024-01-12

4. Impact of Dosing and Duration of Dexamethasone on Serious Corticosteroid-Related Adverse Events;Journal of Pain and Symptom Management;2024-01

5. Atemnot;Onkologische Krankenpflege;2024